Testosterone Therapy: Mechanism, Monitoring & Clinical Evidence

The Testosterone Axis: What Actually Needs Monitoring

Testosterone therapy remains one of the most mismanaged interventions in functional medicine—not because the hormone is dangerous, but because most practitioners skip the foundational work: understanding the hypothalamic-pituitary-gonadal (HPG) axis and establishing baseline metrics before the first dose.

Here's what you need to know before considering exogenous testosterone.

HPG Axis Physiology: The Bottom-Up Story

Your pituitary doesn't care what your testosterone level is. It responds to GnRH (gonadotropin-releasing hormone) from the hypothalamus, which triggers LH and FSH release. LH stimulates Leydig cells to produce testosterone; FSH drives spermatogenesis. Testosterone feeds back to suppress GnRH and LH in a classical negative feedback loop.

When you introduce exogenous testosterone, this axis suppresses—sometimes reversibly, sometimes not. That's not a side effect; it's pharmacology. The question is whether you've characterized your baseline function first.

Mandatory Pre-Therapy Labs

Testosterone panel:

Total testosterone (optimal range: 500–900 ng/dL for most men; reference range often stops at 700 ng/dL)
Free testosterone (9–30 pg/mL is typical)
SHBG (sex hormone-binding globulin: 30–100 nmol/L)

HPG axis function:

LH (1.7–8.6 mIU/mL)
FSH (1.5–12.4 mIU/mL)
Prolactin (<15 ng/mL)

Metabolic and liver function:

Fasting glucose and HbA1c (testosterone increases insulin sensitivity in some men, worsens it in others—baseline matters)
AST, ALT, GGT (methylated androgens don't stress liver; injectables don't either, but you need baseline)
Lipid panel (total cholesterol, HDL, LDL, triglycerides)

Hematologic:

Complete blood count (CBC) with hematocrit—testosterone increases RBC production; baseline establishes your ceiling
Hemoglobin (some men are polycythemic responders; >54% hematocrit warrants caution)

Cardiovascular risk:

Systolic/diastolic blood pressure (testosterone can elevate BP in salt-sensitive individuals)
Homocysteine (optional but valuable; testosterone lowers it in most men)

PSA and digital rectal exam: Controversial, but mandatory. Not because testosterone causes prostate cancer (it doesn't), but because you cannot interpret future PSA changes without knowing your baseline.

Dosing Strategy & Monitoring Cadence

Once labs are established, dosing depends on the ester and route:

Injectable testosterone (cypionate or enanthate):

Typical dose: 100–200 mg/week, split into two administrations
Peak levels: 48–72 hours post-injection
Steady state: achieved by week 4–6
Recheck labs at 6 weeks, then every 12 weeks thereafter

Transdermal (cream, gel, patch):

Steadier pharmacokinetics; recheck at 4 weeks
Better for men with polycythemic tendency or estradiol sensitivity

Pellets:

Sustained release; 6–month duration typical
Harder to titrate; not recommended for first-time users

The Estradiol Consideration

Testosterone aromatizes to estradiol at ~0.3% daily. In some men, exogenous testosterone pushes estradiol above 40–50 pg/mL, triggering gynecomastia, fluid retention, and mood changes. This is not universal. Your baseline aromatase activity (estimated by pre-therapy testosterone:estradiol ratio) predicts your response.

If you have high baseline estradiol relative to testosterone, an AI (aromatase inhibitor) like anastrozole (0.5 mg twice weekly) during testosterone therapy is reasonable. But do not start an AI preemptively. Measure first.

Synergistic Supplements During Therapy

If you're optimizing the HPG axis or using testosterone replacement:

Zinc picolinate (25–30 mg/day): Required for LH synthesis and testosterone production
Magnesium glycinate (400–500 mg/day): Reduces SHBG, increases free testosterone; supports sleep quality
Vitamin D3 (2000–4000 IU/day to 25-OH level of 50–70 ng/mL): Upregulates androgen receptors
Omega-3 (2–3 g/day EPA+DHA): Improves lipid profile during therapy; protective cardiovascular effect
NAC (1200–1800 mg/day): Supports liver glutathione during hormonal shifts
Ashwagandha (600 mg/day): May improve cortisol:testosterone ratio and sexual function

These are not substitutes for testosterone therapy if you're genuinely deficient. They're optimization tools alongside it.

What Testosterone Therapy Actually Changes

Beyond the obvious (libido, strength, body composition), testosterone shifts:

Myelin production (cognitive speed)
Dopamine and serotonin signaling (mood, motivation)
RBC hematocrit (oxygen-carrying capacity, endurance)
Collagen synthesis (skin thickness, tendon resilience)
Insulin sensitivity (in most responders; glucose control improves)

But these gains only materialize if you've started from a confirmed hypogonadal state and you're monitoring continuously. Replacing someone who's already at 600 ng/dL will not improve outcomes; it will only suppress their axis and increase side effects.

Bottom Line

Testosterone therapy is powerful and, when indicated, transformative. But it demands baseline bloodwork, clear dosing protocols, and serial monitoring every 6–12 weeks. Do not let a provider start you on testosterone without establishing your pre-therapy testosterone, LH, FSH, estradiol, hematocrit, lipids, and PSA. And do not expect results without synergistic supplementation (zinc, vitamin D3, magnesium glycinate, omega-3) and lifestyle consistency (resistance training, sleep, caloric adequacy).

The hormone is the tool. The testing is the instruction manual.

Disclaimer: This content is for educational purposes only and does not constitute medical advice.